The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 356:1577-1579 April 12, 2007 Number 15
NextNext

Retinal Progenitor Cells — Timing Is Everything
Jean Bennett, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
More than 10 million people in the United States are blind or visually impaired, and 50,000 more will become blind each year. The results of a survey conducted by the American Foundation for the Blind indicate that people with diabetes fear blindness even more than premature death.1 Retinal repair by means of the transplantation of photoreceptor precursors, recently described by MacLaren and colleagues,2 thus holds hope for many people.

Blindness is often caused by degenerative conditions in which the sensory cells in the retina deteriorate and die. Such conditions include retinitis pigmentosa and age-related macular degeneration. Photoreceptors do not divide . . . [Full Text of this Article]


Source Information

From Scheie Eye Institute, University of Pennsylvania, Philadelphia.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.